Haochen Zhang

10PUBLICATIONS

116CO-AUTHORS

Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPhylogeny and comparative analysis

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|Jul 08, 2026

Development and Validation of a Computational Histology Artificial Intelligence-Powered Biomarker in Metastatic Hormone-Sensitive Prostate Cancer on Randomized Phase III Trials.

|Mar 27, 2026

POLQ-driven repair scars shape the immunogenic landscape of homologous recombination-deficient pancreatic cancer.

Wungki Park, Shigeaki Umeda, Marc Hilmi

|Mar 26, 2026

Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial.

Wungki Park, Catherine A O'Connor, Joanne F Chou

|Feb 11, 2026

Development and Validation of a Computational Histology Artificial Intelligence-Powered Predictive Biomarker for Selection of Chemotherapy in Advanced Pancreatic Cancer.

Andrew E Hendifar, Viswesh Krishna, Vrishab Krishna

|Feb 06, 2026

Convergence for Inactivation of TGFβ Signaling Is a Common Feature of Advanced Pancreatic Cancer.

Jungeui Hong, Zachary A Kohutek, Haochen Zhang

|Jan 22, 2026

Genomic evolution of pancreatic cancer at single-cell resolution.

Haochen Zhang, Palash Sashittal, Elias-Ramzey Karnoub

Pageof 2

Frequent Collaborators

8 joint publications

Christine Iacobuzio-Donahue

Elias-Ramzey Karnoub

Shigeaki Umeda

Eileen O'Reilly

Akimasa Hayashi

Wungki Park

Anna Varghese

Walid K Chatila

Michael Foote

Marc Hilmi

Frequent Collaborators

8 joint publications

Christine Iacobuzio-Donahue

6 joint publications

Elias-Ramzey Karnoub

5 joint publications

Shigeaki Umeda

5 joint publications

Eileen O'Reilly